The U.S. Food and Drug Administration gave De Novo clearance to Techsomed's BioTraceIO, which leverages a computational algorithm to analyze ultrasound images captured during liver ablation treatment ...

In patients with recurrent small hepatocellular carcinoma (HCC), stereotactic body radiotherapy (SBRT) demonstrated superior local progression-free survival (PFS) and tumor control at 3 years compared ...

Microwave ablation (MWA) of colorectal liver metastases (CRLM) had low rates of failure and morbidity and warrants consideration as definitive treatment, authors of a large clinical review suggested.

Chicago — Surgical resection is the standard of care for small colorectal liver metastases, but the results of a phase 3 trial reported at the American Society of Clinical Oncology (ASCO) 2024 annual ...

Cleveland Clinic is the first hospital in the world to use a recently FDA-approved ablation technology that can destroy large liver tumors. The minimally invasive procedure uses a single needle ...

Surgery and radiofrequency ablation showed similar 5-year survival rates for small liver tumors. Both treatments had nearly identical 5-year recurrence-free survival outcomes. Patient and tumor ...

DNA cytometric parameters as prognostic factors of chemoimmunotherapy for ovarian cancer. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does not include a full ...

This section describes efficacy outcomes from the published literature that the committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see ...

Phase Ib dose escalation and cohort expansion study of the novel myeloid differentiating agent MTL-CEBPA in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC). A ...

Treatment options for liver cancer vary based on the cancer stage and a person’s overall health and liver function. A person should work with their treatment team to determine the best treatment ...